Viewing StudyNCT00044486



Ignite Creation Date: 2024-05-05 @ 11:28 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00044486
Status: COMPLETED
Last Update Posted: 2017-03-10
First Post: 2002-08-29

Brief Title: Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients Study P01899
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Conditions & Keywords Data

Conditions:
Name
Neutropenia
Leukemia Myelocytic Acute
Myelodysplastic Syndromes
Keywords:
Name View
Anticipated prolonged profound neutropenia View
Prophylaxis View
neutropenia View
AML View
MDS View
fungal infections View
Acute Myelogenous Leukemia View